Our research
Responding to global health challenges relative to their urgency and the availability of meaningful drug therapies.
Four Therapeutic Areas capture research projects at the Centre, based around cancer, infectious diseases, neurological & CNS disorders and cardiovascular disease.
Within each area, a critical mass of multidisciplinary researchers work synergistically to resolve a series of interlinked questions through one of four DDI-funded Priority-Driven Programs (PDP).
Each program is designed by lead researchers to offset wider aims with tangible progress over three years.
We progress drug design innovation at an intersection of internationally awarded expertise, novel ideas and advanced techniques. Sustainable collaborative practice sits at the core of our research ethos.
Our research is categorised according to four foundational Therapeutic Areas, representing identified points of highly sought but underserved clinical need.
These areas form an essential overview of how our research mission is executed operationally, and signifies points of research interest for researchers, collaborators and external stakeholders.
Harnessing cutting edge techniques to tackle difficult-to-treat brain and central nervous system disorders.
Our research addresses infectious diseases which pose a pre-existing and ongoing risk to global health by developing novel therapeutics.
While there are a range of existing treatments for different forms of cancer, they require continuous refinement to target the disease accurately and effectively.
Seeking to control and inhibit prevalent syndromes through molecular technologies.
